161 related articles for article (PubMed ID: 35405256)
1. Serum proteomic analysis reveals the cardioprotective effects of Shexiang Baoxin Pill and Suxiao Jiuxin Pill in a rat model of acute myocardial infarction.
Song N; Lu D; Wu G; Wang S; Zeng Y; Zhao J; Meng Q; He H; Chen L; Zhu H; Liu A; Li H; Shen X; Zhang W; Zhou H
J Ethnopharmacol; 2022 Jul; 293():115279. PubMed ID: 35405256
[TBL] [Abstract][Full Text] [Related]
2. Quantitative proteomics reveals Shexiang Baoxin Pill exerts cardioprotective effects by preserving energy metabolism in a rat model of myocardial infarction.
Yu F; Yu Y; Tian S; Zhou Y; Chen X; Ye J; Liu Q; Xu X; Zhou H; Zhang W
J Ethnopharmacol; 2021 Feb; 266():113460. PubMed ID: 33039626
[TBL] [Abstract][Full Text] [Related]
3. Microbiome-metabolome reveals that the Suxiao Jiuxin pill attenuates acute myocardial infarction associated with fatty acid metabolism.
Liao J; Zhang Y; Ma C; Wu G; Zhang W
J Ethnopharmacol; 2023 Aug; 312():116529. PubMed ID: 37086873
[TBL] [Abstract][Full Text] [Related]
4. Effects of the Suxiao Jiuxin pill on acute myocardial infarction assessed by comprehensive metabolomics.
Wu G; Zhong J; Chen L; Gu Y; Hong Y; Ma J; Zheng N; Liu AJ; Sheng L; Zhang W; Li H
Phytomedicine; 2020 Oct; 77():153291. PubMed ID: 32739572
[TBL] [Abstract][Full Text] [Related]
5. Exploring the mechanism underlying the cardioprotective effect of shexiang baoxin pill on acute myocardial infarction rats by comprehensive metabolomics.
Wu G; Chen L; Gu Y; Hong Y; Ma J; Zheng N; Zhong J; Liu AJ; Sheng L; Zhang W; Li H
J Ethnopharmacol; 2020 Sep; 259():113001. PubMed ID: 32464316
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of Shexiang Baoxin Pill combined with Western medicine in the treatment of acute myocardial infarction: A single-center, double-blind, randomized controlled trial.
Yang Y; Gao S; Fang Q; Zhu M
Medicine (Baltimore); 2021 Jan; 100(3):e24246. PubMed ID: 33546045
[TBL] [Abstract][Full Text] [Related]
7. Effects on Suxiao Jiuxin Pills in the Treatment of Patients with Acute Coronary Syndrome Undergoing Early Percutaneous Coronary Intervention: A Multicenter Randomized Double-Blind Placebo-Controlled Trial.
Shen Z; Chen T; Deng B; Fan M; Hua J; Zhang M; Wang X
J Altern Complement Med; 2020 Nov; 26(11):1055-1063. PubMed ID: 32716206
[No Abstract] [Full Text] [Related]
8. Shexiang Baoxin pills promotes angiogenesis in myocardial infarction rats via up-regulation of 20-HETE-mediated endothelial progenitor cells mobilization.
Huang F; Liu Y; Yang X; Che D; Qiu K; Hammock BD; Wang J; Wang MH; Chen J; Huang H
Atherosclerosis; 2017 Aug; 263():184-191. PubMed ID: 28646793
[TBL] [Abstract][Full Text] [Related]
9. Suxiao Jiuxin Pill attenuates acute myocardial ischemia via regulation of coronary artery tone.
Li S; Zhan J; Wang Y; Oduro PK; Owusu FB; Zhang J; Leng L; Li R; Wei S; He J; Wang Q
Front Pharmacol; 2023; 14():1104243. PubMed ID: 37234713
[TBL] [Abstract][Full Text] [Related]
10. Shexiang Baoxin Pill enriches Lactobacillus to regulate purine metabolism in patients with stable coronary artery disease.
Wu G; Liao J; Zhu X; Zhang Y; Lin Y; Zeng Y; Zhao J; Zhang J; Yao T; Shen X; Li H; Hu L; Zhang W
Phytomedicine; 2024 Jul; 130():155727. PubMed ID: 38781732
[TBL] [Abstract][Full Text] [Related]
11. Study of the mechanism of Shexiang Baoxin pill-mediated angiogenesis in acute myocardial infarction.
Wei J; Dong B; Du X; Xu H
Cardiovasc J Afr; 2023 Jul; 34():1-7. PubMed ID: 37526966
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of angiogenesis promotion with Shexiang Baoxin Pills by regulating function and signaling pathway of endothelial cells through macrophages.
Zhang J; Cui Q; Zhao Y; Guo R; Zhan C; Jiang P; Luan P; Zhang P; Wang F; Yang L; Yang X; Xu Y
Atherosclerosis; 2020 Jan; 292():99-111. PubMed ID: 31785495
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the efficacy and safety of Suxiao Jiuxin Pill in the treatment of stable angina: A randomized, double-blind, placebo-controlled, multi-center clinical trial.
Sun YL; Yao YL; Jia MJ; Sun YY; Li HL; Ruan XF; Wang XL
J Ethnopharmacol; 2024 Jan; 318(Pt A):116959. PubMed ID: 37487965
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and tissue distribution of five bufadienolides from the Shexiang Baoxin Pill following oral administration to mice.
Huang H; Yang Y; Lv C; Chang W; Peng C; Wang S; Ge G; Han L; Zhang W; Liu R
J Ethnopharmacol; 2015 Feb; 161():175-85. PubMed ID: 25196822
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of potential herb-drug interactions based on the effect of Suxiao Jiuxin Pill on CYP450 enzymes and transporters.
Qiang T; Li Y; Wang K; Lin W; Niu Z; Wang D; Wang X
J Ethnopharmacol; 2021 Nov; 280():114408. PubMed ID: 34252529
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of the Shexiang Baoxin Pill for the treatment of coronary artery disease not amenable to revascularisation: study protocol for a randomised, placebo-controlled, double-blinded trial.
Tian PP; Li J; Gao J; Li Y
BMJ Open; 2018 Feb; 8(2):e018052. PubMed ID: 29444778
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacokinetics of five ginsenosides of Shexiang Baoxin pill in plasma of myocardial infarction rats].
Liu Q; Wu R; Lv C; Zhang WD; Liu RH
Zhongguo Zhong Yao Za Zhi; 2017 Jan; 42(1):162-169. PubMed ID: 28945043
[TBL] [Abstract][Full Text] [Related]
18. Study on anti-atherosclerotic effect of Suxiao Jiuxin Pill and its mechanism.
Guo QX; Zhang J; Li YQ; Zhang GF
Afr J Tradit Complement Altern Med; 2014; 11(1):97-102. PubMed ID: 24653560
[TBL] [Abstract][Full Text] [Related]
19. Suxiao Jiuxin pill promotes exosome secretion from mouse cardiac mesenchymal stem cells in vitro.
Ruan XF; Ju CW; Shen Y; Liu YT; Kim IM; Yu H; Weintraub N; Wang XL; Tang Y
Acta Pharmacol Sin; 2018 Apr; 39(4):569-578. PubMed ID: 29542682
[TBL] [Abstract][Full Text] [Related]
20. Biomarkers in the early period of acute myocardial infarction in rat serum and protective effects of Shexiang Baoxin Pill using a metabolomic method.
Jiang P; Dai W; Yan S; Chen Z; Xu R; Ding J; Xiang L; Wang S; Liu R; Zhang W
J Ethnopharmacol; 2011 Nov; 138(2):530-6. PubMed ID: 22001859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
